Tweeter button Delicious button Digg button Stumbleupon button
Cirrhosis | Research And Markets: Global Liver Cirrhosis Pipeline Highlights 2014-2017

DUBLIN–( BUSINESS WIRE )– Research and Markets ( ) has announced the addition of the “Liver Cirrhosis Pipeline Highlights – 2014 Update” report to their offering.

The latest report Liver Cirrhosis Pipeline Highlights – 2014 Update, provides most up-to-date information on key pipeline molecules in the global Liver Cirrhosis market. It covers emerging therapies for Liver Cirrhosis in active clinical development stages including early and late stage clinical trials. The pipeline data presented in this report helps executives for tracking competition, identifying partners, evaluating opportunities, formulating business development strategies, and executing in-licensing and out-licensing deals.

Clinical Trial Stages:

The report provides Liver Cirrhosis pipeline molecules by clinical trial stages including both early and late stage development – phase 3 clinical trials, phase 2 clinical trials, phase 1 clinical trials, preclinical research, and discovery stage.

Drug Mechanism Classes:

The report provides Liver Cirrhosis pipeline molecules by their dominant mechanism of action. This helps executives categorize molecules based on their drug

Click here to view rest of article from original site

Facebook Twitter Email

Posted on July 15, 2014, 8:41 pm By
Categories: cirrhosis Tags:
Important Disclaimer: Article Comments provided are for general information purposes only and are not intended to substitute for informed professional medical, psychological, tax, accounting, legal, investment, or any other professional advice. We expressly disclaim liability for any product, manufacturer, distributor, service or service provider mentioned or any opinion expressed in these comments or anywhere else within the site. Lastly, we do not endorse any article or comment. Use at your own risk.